Joseph J. Buggy
- Genetics top 0.05%
- Pathology and Forensic Medicine top 0.2%
- Molecular Biology top 2%
- Immunology top 1%
- Oncology top 2%
- Co-authors
- Betty ChangErik VernerMint SirisawadSriram BalasubramanianRichard A. MillerLee HonigbergJan A. BurgerAhmed Hamdy
- Topics
- Chronic Lymphocytic Leukemia Research (45 papers)Lymphoma Diagnosis and Treatment (21 papers)Histone Deacetylase Inhibitors Research (14 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Joseph J. Buggy
81 papers receiving 7.1k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Genetics 4.1k
- Pathology and Forensic Medicine 3.1k
- Molecular Biology 2.9k
- Immunology 2.1k
- Oncology 1.5k
Countries citing papers authored by Joseph J. Buggy
This map shows the geographic impact of Joseph J. Buggy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph J. Buggy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph J. Buggy more than expected).
Fields of papers citing papers by Joseph J. Buggy
This network shows the impact of papers produced by Joseph J. Buggy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph J. Buggy. The network helps show where Joseph J. Buggy may publish in the future.
Co-authorship network of co-authors of Joseph J. Buggy
This figure shows the co-authorship network connecting the top 25 collaborators of Joseph J. Buggy. A scholar is included among the top collaborators of Joseph J. Buggy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph J. Buggy. Joseph J. Buggy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 162 | |
| 3 | 8 | |
| 4 | 159 | |
| 5 | 64 | |
| 6 | 46 | |
| 7 | 153 | |
| 8 | Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignanciesbreakdown → | 848 |
| 9 | 172 | |
| 10 | 174 | |
| 11 | 50 | |
| 12 | Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765breakdown → | 607 |
| 13 | 82 | |
| 14 | 363 | |
| 15 | PCI-27483, a small molecule inhibitor of factor VIIa, inhibits tumor growth in vivo. | 1 |
| 16 | 7 | |
| 17 | 9 | |
| 18 | 52 | |
| 19 | 2 | |
| 20 | 14 |
About Joseph J. Buggy
Joseph J. Buggy is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 83 papers that have together received 7.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (45 papers), Lymphoma Diagnosis and Treatment (21 papers) and Histone Deacetylase Inhibitors Research (14 papers). The work is most often cited by research in Genetics (4.1k citations), Pathology and Forensic Medicine (3.1k citations) and Hematology (1.3k citations). Joseph J. Buggy has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Betty Chang, Erik Verner, Mint Sirisawad, Sriram Balasubramanian, Richard A. Miller, Lee Honigberg, Jan A. Burger, Ahmed Hamdy, David Loury and Carl E. Bauer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.